JOINT INTERACTION OF SOD2, EDN1, AND eNOS GENE POLYMORPHISMS IN THE DEVELOPMENT OF CEREBROVASCULAR DISEASES
Keywords:
SOD2 (Ala16Val), EDN1 (Lys197Asn), eNOS (T786C) polymorphisms, cerebrovascular diseasesAbstract
The article investigates the role of synergistic interactions between polymorphisms in the genes SOD2 (Ala16Val), EDN1 (Lys197Asn), and eNOS (T786C) in the development of cerebrovascular diseases (CVD). The primary focus emphasizes that the true pathogenetic significance of these genetic variants manifests not individually, but through their synergy.
Results of the study: SOD2: The Val/Val genotype is significantly associated with a high risk of CVD (OR=3.3, p=0.01). The combination of Val/Val and Val/Ala genotypes further elevates the risk. EDN1: The Asn allele and Asn/Asn genotype show a potential association with increased CVD risk, characterized by high sensitivity (SE=0.71–0.81) but low specificity (SP=0.23–0.29), limiting their standalone diagnostic value. eNOS: The individual association of the T786C polymorphism with stroke is statistically insignificant (OR=0.88, p=0.65). The C/C and C/T genotypes exhibit low specificity (SP=0.25). Combined effect: The presence of one unfavorable genotype across any gene significantly increases CVD risk (OR=2.48, p=0.006). A clear trend of rising risk proportional to the number of unfavorable genotypes was observed. The most pronounced effect occurred with the combination of three unfavorable genotypes simultaneously (OR=2.92, p=0.061).
References
Marsi T, et al. Superoxide dismutase 2 (SOD2) Ala16Val polymorphism and ischemic stroke: A meta-analysis. J Stroke Cerebrovasc Dis. 2018;27(8):2099-2107.
Fukuda T, et al. The Ala16Val polymorphism of the manganese superoxide dismutase gene is associated with increased risk of ischemic stroke in Japanese subjects. J Neurol Sci. 2011;306(1-2):106-109.
Парфенов В.А., и соавт. Ассоциация полиморфизма гена SOD2 (Ala-9Val) с развитием и прогрессированием дисциркуляторной энцефалопатии. Журнал неврологии и психиатрии им. С.С. Корсакова. 2012;112(9):34-37.
Schafer S, et al. The manganese superoxide dismutase Ala16Val polymorphism is associated with cerebral white matter hyperintensities. Stroke. 2009;40(3):639-644.
Chen Y, et al. SOD2 polymorphism and mortality after ischemic stroke: a cohort study and meta-analysis. Sci Rep. 2017;7:46676.
Zhang B, et al. Endothelin-1 Lys198Asn polymorphism and ischemic stroke risk: a meta-analysis. J Neurol. 2013;260(7):1845-1851.
Tiret L, et al. The endothelin-1 gene Lys198Asn polymorphism is associated with lacunar stroke. Stroke. 2005;36(3):618-620.
Barden AE, et al. Endothelin-1 Lys198Asn polymorphism is associated with elevated blood pressure. Hypertension. 2001;38(3 Pt 2):688-692. (Связь с АГ).
Скворцова В.И., и соавт. Полиморфизм гена эндотелина-1 (EDN1) у больных с дисциркуляторной энцефалопатией. Анналы клинической и экспериментальной неврологии. 2010;4(3):12-15.
Dengel DR, et al. The Lys198Asn polymorphism in the endothelin-1 gene is associated with increased carotid intima-media thickness in older adults. Am J Hypertens. 2008;21(1):9-14.
Zhang B, et al. Endothelial nitric oxide synthase gene 4b/a polymorphism and ischemic stroke susceptibility: a meta-analysis. J Neurol Sci. 2014;346(1-2):83-88.
Yang J, et al. Endothelial nitric oxide synthase Glu298Asp polymorphism and ischemic stroke risk: a meta-analysis. Neurosci Lett. 2013;548:84-89.
Li N, et al. Endothelial nitric oxide synthase gene polymorphisms and risk of hemorrhagic stroke: a systematic review and meta-analysis. Mol Neurobiol. 2015;52(2):972-982.
Khan U, et al. Endothelial nitric oxide synthase gene variants and vascular dementia: a case-control study. Brain Res. 2010;1358:192-197.
Huang J, et al. Association of endothelial nitric oxide synthase gene polymorphisms with vascular dementia: a meta-analysis. J Neurol Sci. 2013;333(1-2):38-43.
Miyamoto Y, et al. Association of the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene with essential hypertension. Hypertens Res. 2006;29(7):481-486.
Slowik A, et al. Endothelial nitric oxide synthase gene polymorphism and functional outcome after ischemic stroke. Stroke. 2005;36(1):62-65.
Li L, et al. Endothelin-1 stimulates superoxide production in human vascular smooth muscle cells via NADPH oxidase activation. Am J Physiol Heart Circ Physiol. 2003;284(3):H907-H912.
Forstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J. 2012;33(7):829-837. (Обзор функций NO и его инактивации O₂⁻).
Boulanger CM, Luscher TF. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest. 1990;85(2):587-590.
Davenport AP, Maguire JJ. Endothelin. Handb Exp Pharmacol. 2011;(200 Pt 1):293-321.
Wang XL, et al. Combined effect of SOD2, EDN1, and eNOS gene polymorphisms on ischemic stroke risk in a Chinese population. J Stroke Cerebrovasc Dis. 2014;23(8):1991-1996.
Senthil D, et al. Synergistic effect of SOD2 and eNOS gene polymorphisms on the risk of ischemic stroke in an Asian Indian population. J Neurol Sci. 2011;303(1-2):87-91.
Petrova D, et al. Association of SOD2, EDN1, and eNOS gene polymorphisms with cerebral small vessel disease severity. Cerebrovasc Dis Extra. 2017;7(1):1-10.
Dudzinski DM, et al. eNOS polymorphisms and response to statin therapy. Pharmacogenomics J. 2011;11(5):345-353.
Koh KK, et al. Effects of statin therapy on circulating concentrations of endothelin-1. Am J Cardiol. 2000;85(7):896-898.
